Orchestra BioMed Holdings annual current ratio
2020
2021
2022
2023
2024
2025
Orchestra BioMed Holdings Current Ratio Growth & History (OBIO)
Orchestra BioMed Holdings's current ratio was 6.45 for fiscal 2025.
View full Orchestra BioMed Holdings company overviewOrchestra BioMed Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.45 | 2.18 | +51.08% |
| 2024 | 2024-12-31 | 4.27 | −3.68 | −46.32% |
| 2023 | 2023-12-31 | 7.95 | 3.39 | +74.30% |
| 2022 | 2022-12-31 | 4.56 | −6.32 | −58.08% |
| 2021 | 2021-12-31 | 10.88 | −7.19 | −39.78% |
| 2020 | 2020-12-31 | 18.07 | — | — |
Orchestra BioMed Holdings quarterly current ratio
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.26 | 6.15 | +292.64% |
| Q1 2026 | 2026-03-31 | 7.03 | 3.68 | +109.69% |
| Q4 2025 | 2025-12-31 | 6.45 | 2.18 | +51.08% |
| Q3 2025 | 2025-09-30 | 4.73 | 0.51 | +11.98% |
| Q2 2025 | 2025-06-30 | 2.10 | −2.48 | −54.12% |
| Q1 2025 | 2025-03-31 | 3.35 | −3.99 | −54.33% |
| Q4 2024 | 2024-12-31 | 4.27 | −3.68 | −46.32% |
| Q3 2024 | 2024-09-30 | 4.23 | −0.90 | −17.63% |
| Q2 2024 | 2024-06-30 | 4.58 | −5.50 | −54.54% |
| Q1 2024 | 2024-03-31 | 7.34 | −3.43 | −31.88% |
| Q4 2023 | 2023-12-31 | 7.95 | 3.39 | +74.30% |
| Q3 2023 | 2023-09-30 | 5.13 | 4.53 | +747.17% |
| Q2 2023 | 2023-06-30 | 10.08 | 8.86 | +724.07% |
| Q1 2023 | 2023-03-31 | 10.77 | 5.91 | +121.59% |
| Q4 2022 | 2022-12-31 | 4.56 | −6.32 | −58.08% |
| Q3 2022 | 2022-09-30 | 0.61 | −13.02 | −95.55% |
| Q2 2022 | 2022-06-30 | 1.22 | −9.13 | −88.18% |
| Q1 2022 | 2022-03-31 | 4.86 | −7.13 | −59.48% |
| Q4 2021 | 2021-12-31 | 10.88 | −7.19 | −39.78% |
| Q3 2021 | 2021-09-30 | 13.63 | −17.14 | −55.71% |
| Q2 2021 | 2021-06-30 | 10.35 | — | — |
| Q1 2021 | 2021-03-31 | 12.00 | — | — |
| Q4 2020 | 2020-12-31 | 18.07 | — | — |
| Q3 2020 | 2020-09-30 | 30.76 | — | — |
Orchestra BioMed Holdings current ratio trends
Over the last five fiscal years, Orchestra BioMed Holdings's current ratio decreased from 18.07 to 6.45, a change of −11.62. The latest reported quarter, Q2 2026, shows 8.26.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orchestra BioMed Holdings source filings ↗